Inventor · disambiguated record
John Wityak
Also filed as: WITYAK JOHN
49 granted patents·8 pending applications·1,161 citations·filing 1994–2022
98Inventor score
Files withBRISTOL MYERS SQUIBB CO18CHDI FOUNDATION INC11DU PONT MERCK PHARMA9WITYAK JOHN4DU PONT PHARM CO3
Top patents by PatentIndex Score
57 records- 0198US6596746B1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 22, 2003·257 cites·49 claims
- 0297US7153856B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·38 cites·8 claims
- 0396US9382219B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 5, 2016·17 cites·11 claims
- 0496US6706717B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 16, 2004·73 cites·11 claims
- 0594US7125875B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 24, 2006·74 cites·27 claims
- 0693US11344637B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2020·Granted May 31, 2022·3 cites·22 claims
- 0793US7241781B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jul 10, 2007·17 cites·16 claims
- 0893US5563127ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1994·Granted Oct 8, 1996·74 cites·7 claims
- 0992US11059836B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2019·Granted Jul 13, 2021·8 cites·23 claims
- 1091US11071793B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Jul 27, 2021·5 cites·20 claims
- 1191US10479802B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Nov 19, 2019·8 cites·25 claims
- 1291US8889716B2Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereofPRIME MICHAEL·Filed 2012·Granted Nov 18, 2014·34 cites·14 claims
- 1391US6358976B1Integrin receptor antagonistsFiled 2000·Granted Mar 19, 2002·88 cites·18 claims
- 1490US12258355B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2022·Granted Mar 25, 2025·1 cites·14 claims
- 1590US10137211B2Probes for imaging Huntingtin proteinCHDI FOUNDATION INC·Filed 2016·Granted Nov 27, 2018·6 cites·40 claims
- 1690US7091223B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 15, 2006·21 cites·12 claims
- 1790US6979694B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 27, 2005·23 cites·11 claims
- 1889US10765764B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2018·Granted Sep 8, 2020·4 cites·27 claims
- 1989US8716323B2Cyclic protein tyrosine kinase inhibitorsDAS JAGABANDHU·Filed 2005·Granted May 6, 2014·9 cites·20 claims
- 2088US5698538ABoronic acid and ester inhibitors of thrombinDU PONT MERCK PHARMA·Filed 1996·Granted Dec 16, 1997·42 cites·7 claims
- 2187US12036291B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2021·Granted Jul 16, 2024·1 cites·11 claims
- 2286US6825355B2Benzothiazole protein trosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 30, 2004·27 cites·2 claims
- 2386US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 2485US5710159AIntegrin receptor antagonistsDU PONT MERCK PHARMA·Filed 1996·Granted Jan 20, 1998·39 cites·21 claims
- 2584US10907197B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Feb 2, 2021·4 cites·12 claims
- 2684US8536186B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2009·Granted Sep 17, 2013·9 cites·6 claims
- 2784US5446056AIsoxazoline compounds useful as fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1994·Granted Aug 29, 1995·27 cites·20 claims
- 2883US8993567B2Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 31, 2015·3 cites·12 claims
- 2982US9145373B2Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereofWITYAK JOHN·Filed 2013·Granted Sep 29, 2015·7 cites·9 claims
- 3081US11104691B2Probes for imaging huntingtin proteinCHDI FOUNDATION INC·Filed 2015·Granted Aug 31, 2021·2 cites·21 claims
- 3180US6130231AIntegrin receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Oct 10, 2000·54 cites·18 claims
- 3276US6649606B1Tetrahydroisoquinoline analogs as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 18, 2003·12 cites·12 claims
- 3374US5939418AIsoxazoline, isothiazoline and pyrazoline factor Xa inhibitorsDU PONT MERCK PHARMA·Filed 1996·Granted Aug 17, 1999·19 cites·12 claims
- 3472US2019210986A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3571US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 3671US5811441AIsoxazoline fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1997·Granted Sep 22, 1998·14 cites·20 claims
- 3769US11851446B2Probes for imaging Huntingtin proteinCHDI FOUNDATION INC·Filed 2021·Granted Dec 26, 2023·0 cites·9 claims
- 3869US8946197B2Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereofDOMINGUEZ CELIA·Filed 2010·Granted Feb 3, 2015·1 cites·50 claims
- 3969US6958336B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 25, 2005·2 cites·17 claims
- 4069US6956045B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 18, 2005·2 cites·17 claims
- 4169US6953795B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 11, 2005·2 cites·17 claims
- 4267US2018016247A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 4366US7037926B2Thiazolyl inhibitors of Tec family tyrosine kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 2, 2006·1 cites·17 claims
- 4466US5773411ACyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIB/IIIADU PONT MERCK PHARMA·Filed 1994·Granted Jun 30, 1998·17 cites·12 claims
- 4564US2016264537A1Cyclic protein tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 4660US6455560B1Isoxazoline fibrinogen receptor antagonistsFiled 2001·Granted Sep 24, 2002·1 cites·12 claims
- 4760US5849693ACyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIaDU PONT MERCK PHARMA·Filed 1997·Granted Dec 15, 1998·14 cites·18 claims
- 4855US2013345220A1Compounds and compositions as lxr modulatorsMOLTENI VALENTINA·Filed 2013·Application pending·0 cites
- 4953US8569345B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2012·Granted Oct 29, 2013·0 cites·6 claims
- 5053US8158662B2Compounds and compositions as LXR modulatorsMOLTENI VALENTINA·Filed 2005·Granted Apr 17, 2012·0 cites·6 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Wityak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →